Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$119,167.00
Sep 1, 2012
Deformable Dose Reconstruction to Optimize the Planning and Delivery of Liver Cancer Radiation Therapy
$135,000.00
Jul 1, 2012
Cardiolipin synthesis as a therapy for heart failure in persistent pulmonary hypertension
$300,000.00
Jul 1, 2012
Genome folding and regulation of gene expression
$300,000.00
Jul 1, 2012
Robotic assisted transcranial magnetic stimulation therapy
$205,000.00
Jul 1, 2012
Targeting the loss of the von Hippel-Lindau tumor suppressor gene at a late-stage of autophagy for the development of anticancer therapy
$116,250.00
Jul 1, 2012
Identification of host genes that directly impact susceptibility to infection by Herpes Simplex Virus type 1: from mouse model to human.
$180,000.00
Jun 1, 2012
Developing novel treatments for acute kidney injury: Slit2 as a novel therapy for renal ischemia-perfusion injury
$135,000.00
Jun 1, 2012
Examining the Possible Role of Dopamine and Glutamate Gene Networks in Response Inhibition to Understand the Genetics of Childhood Neuropsychiatric Disorders.
$99,460.00
Jun 1, 2012
Association between antidepressant therapies and their impact on bone mineral density change, risk of bone fractures and falls: a systematic review
$105,000.00
May 1, 2012
Contribution of reperfusion therapy to ischemia/ reperfusion injury in acute myocardial infarction